Susquehanna International Group’s ETF Series Solutions Trust Range Cancer Therapeutics ETF CNCR Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-28,710
| Closed | -$271K | – | 6493 |
|
|
2025
Q1 | $271K | Sell |
28,710
-15,970
| -36% | -$151K | ﹤0.01% | 5144 |
|
|
2024
Q4 | $550K | Buy |
44,680
+33,659
| +305% | +$414K | ﹤0.01% | 3919 |
|
|
2024
Q3 | $165K | Sell |
11,021
-9,535
| -46% | -$143K | ﹤0.01% | 4912 |
|
|
2024
Q2 | $278K | Buy |
+20,556
| New | +$278K | ﹤0.01% | 4317 |
|
|
2024
Q1 | – | Sell |
-40,027
| Closed | -$539K | – | 5700 |
|
|
2023
Q4 | $539K | Buy |
40,027
+3,597
| +10% | +$48.5K | ﹤0.01% | 3748 |
|
|
2023
Q3 | $399K | Sell |
36,430
-2,929
| -7% | -$32.1K | ﹤0.01% | 3717 |
|
|
2023
Q2 | $509K | Buy |
39,359
+24,688
| +168% | +$319K | ﹤0.01% | 3600 |
|
|
2023
Q1 | $176K | Sell |
14,671
-22,490
| -61% | -$270K | ﹤0.01% | 4954 |
|
|
2022
Q4 | $510K | Sell |
37,161
-7,315
| -16% | -$100K | ﹤0.01% | 3196 |
|
|
2022
Q3 | $652K | Buy |
44,476
+31,374
| +239% | +$460K | ﹤0.01% | 3145 |
|
|
2022
Q2 | $199K | Buy |
13,102
+2,858
| +28% | +$43.4K | ﹤0.01% | 4570 |
|
|
2022
Q1 | $184K | Sell |
10,244
-10,335
| -50% | -$186K | ﹤0.01% | 4878 |
|
|
2021
Q4 | $490K | Buy |
20,579
+10,712
| +109% | +$255K | ﹤0.01% | 3841 |
|
|
2021
Q3 | $299K | Sell |
9,867
-15,788
| -62% | -$478K | ﹤0.01% | 4295 |
|
|
2021
Q2 | $817K | Buy |
25,655
+14,940
| +139% | +$476K | ﹤0.01% | 3254 |
|
|
2021
Q1 | $319K | Buy |
+10,715
| New | +$319K | ﹤0.01% | 4303 |
|
|
2020
Q4 | – | Sell |
-32,552
| Closed | -$892K | – | 4811 |
|
|
2020
Q3 | $892K | Buy |
32,552
+24,408
| +300% | +$669K | ﹤0.01% | 2358 |
|
|
2020
Q2 | $222K | Sell |
8,144
-32,906
| -80% | -$897K | ﹤0.01% | 3620 |
|
|
2020
Q1 | $814K | Sell |
41,050
-1,836
| -4% | -$36.4K | ﹤0.01% | 2278 |
|
|
2019
Q4 | $1.01M | Buy |
42,886
+13,276
| +45% | +$311K | ﹤0.01% | 1895 |
|
|
2019
Q3 | $550K | Buy |
+29,610
| New | +$550K | ﹤0.01% | 2787 |
|
|
2019
Q2 | – | Sell |
-17,956
| Closed | -$377K | – | 4564 |
|
|
2019
Q1 | $377K | Sell |
17,956
-43,876
| -71% | -$921K | ﹤0.01% | 2069 |
|
|
2018
Q4 | $1.17M | Buy |
61,832
+20,050
| +48% | +$378K | ﹤0.01% | 1354 |
|
|
2018
Q3 | $1.04M | Buy |
41,782
+9,974
| +31% | +$248K | ﹤0.01% | 1418 |
|
|
2018
Q2 | $768K | Buy |
+31,808
| New | +$768K | ﹤0.01% | 1824 |
|
|
2017
Q4 | – | Sell |
-8,821
| Closed | -$239K | – | 3782 |
|
|
2017
Q3 | $239K | Buy |
+8,821
| New | +$239K | ﹤0.01% | 2633 |
|
|
2016
Q4 | – | Sell |
-48,628
| Closed | -$1.25M | – | 4226 |
|
|
2016
Q3 | $1.25M | Buy |
48,628
+15,674
| +48% | +$404K | ﹤0.01% | 1260 |
|
|
2016
Q2 | $745K | Buy |
+32,954
| New | +$745K | ﹤0.01% | 1884 |
|
|
2016
Q1 | – | Sell |
-24,256
| Closed | -$693K | – | 3908 |
|
|
2015
Q4 | $693K | Buy |
+24,256
| New | +$693K | ﹤0.01% | 2697 |
|